首页 | 本学科首页   官方微博 | 高级检索  
检索        

复合磷酸脂酶片联合多烯磷脂酰胆碱治疗非酒精性脂肪肝的临床疗效观察
引用本文:叶红,綦淑杰.复合磷酸脂酶片联合多烯磷脂酰胆碱治疗非酒精性脂肪肝的临床疗效观察[J].青岛医药卫生,2009,41(3):171-174.
作者姓名:叶红  綦淑杰
作者单位:山东省胶州市人民医院内五科,266300
摘    要:目的探讨复合磷酸脂酶片联合多烯磷脂酰胆碱对非酒精性脂肪肝(NAFLD)的临床治疗作用。方法将63例NAFLD患者随机分为实验组及对照组,实验组应用复合磷酸脂酶片联合多烯磷脂酰胆碱,对照组单纯应用多烯磷脂酰胆碱,检测治疗前后两组谷丙转氨酶(ALT)、谷草转氨酶(AST)、谷胺酰转肽酶(γ-GT)、胆固醇(CH)、甘油三酯(TG)及体重指数(BMI)。结果60天后联合药物组ALT、AST、γ-GT、CH、TG及BMI改善明显,与对照组相比,具有显著性差异(P〈0.05),且联合用药组及对照组均未发现明显不良反应。结论复合磷酸酯酶片联合多烯磷脂酰胆碱在临床上治疗NAFLD具有良好疗效。

关 键 词:非酒精性脂肪肝  复合磷酸脂酶片  多烯磷脂酰胆碱

Clinical Observation on the Treatment of NAFLD with Phosphoesterasum Compositum Combined with Polyene Phosphatidylcholine
Ye Hong,et al..Clinical Observation on the Treatment of NAFLD with Phosphoesterasum Compositum Combined with Polyene Phosphatidylcholine[J].QINGDAO Medical Journal,2009,41(3):171-174.
Authors:Ye Hong  
Institution:Ye Hong,et al.People's Hospital of Jiaozhou.Jiaozhou,266300
Abstract:Objective To observe the therapeutic effectiveness of phosphoesterasum compositum combined with polyene phosphatidylcholine for non-alcohol fatty liver disease(NAFLD).Methods 63 patients with NAFLD were divided into treatment group and control group.The patients in control group only received polyene phosphatidylcholine.Those in treatment group were treated with phosphoesterasum compositum combined with polyene phosphatidylcholine.Before treatment and 60 days after treatment the levels of alanine transamina...
Keywords:Non-alcohol fatty liver disease  Polyene phosphatidylcholine  Phosphoesterasum compositum  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号